Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis.

Key facts

Study ID

NCT02651714

Run by

Vanda Pharmaceuticals

People needed

168

Starts

2016-01-19

Expected to finish

2017-08-04

Last updated by the study team

2024-06-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and non-pregnant, non-lactating female subjects aged 18 - 65 years (inclusive)
• Diagnosed with atopic dermatitis
• Suffering from chronic pruritus with pruritus being actively present

You may not qualify if…

• Chronic pruritus due to condition other than atopic dermatitis (AD)
• Participation in a previous tradipitant (LY686017 or VLY-686) trial
• Anyone affiliated with the site or sponsor and/or anyone who may consent under duress
• Any other sound medical reason as determined by the Investigator including any condition which may lead to an unfavorable risk-benefit of study participation, may interfere with study compliance or may confound study results

Where it is running

• Vanda Investigational Site — Encinitas, California, United States
• Vanda Investigational Site — Encino, California, United States
• Vanda Investigational Site — Lomita, California, United States
• Vanda Investigational Site — San Diego, California, United States
• Vanda Investigational Site — San Diego, California, United States
• Vanda Investigational Site — Miami, Florida, United States
• Vanda Investigational Site — Miami, Florida, United States
• Vanda Investigational Site — Ormond Beach, Florida, United States
• Vanda Investigational Site — Columbus, Georgia, United States
• Vanda Investigational Site — Plainfield, Indiana, United States
• Vanda Investigational Site — Crowley, Louisiana, United States
• Vanda Investigational Site — St Louis, Missouri, United States
• Vanda Investigational Site — Las Vegas, Nevada, United States
• Vanda Investigational Site — New York, New York, United States
• Vanda Investigational Site — New York, New York, United States
• Vanda Investigational Site — High Point, North Carolina, United States
• Vanda Investigational Site — Wilmington, North Carolina, United States
• Vanda Investigational Site — Winston-Salem, North Carolina, United States
• Vanda Investigational Site — Portland, Oregon, United States
• Vanda Investigational Site — Philadelphia, Pennsylvania, United States
• Vanda Investigational Site — Johnston, Rhode Island, United States
• Vanda Investigational Site — Charleston, South Carolina, United States
• Vanda Investigational Site — Houston, Texas, United States
• Vanda Investigational Site — Pflugerville, Texas, United States
• Vanda Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.